See below our active Generic Files :
|
Product |
DMF/ASMF |
CEP |
Country |
|
1,3,5-Trimethoxybenzene |
♦ |
|
Italy |
|
Acetohydroxamic acid |
♦ |
|
USA |
|
Amiodarone hydrochloride |
♦ |
♦ |
Australia, Canada, Europe, USA |
|
Diosmine |
♦ |
♦ |
Europe, Singapore, Spain, USA |
|
Domiphen bromide |
♦ |
|
UK, USA |
|
Econazole nitrate |
♦ |
|
Belgium, France, Italy, USA |
|
Indoramine hydrochloride |
♦ |
|
Ireland, UK, USA |
|
Loperamide hydrochloride |
♦ |
|
Canada, France, USA |
|
Naftazone |
♦ |
|
Belgium, France, Switzerland |
|
Nefopam hydrochloride |
♦ |
|
Canada, France, Ireland, UK, USA |
|
Nifuroxazide |
♦ |
|
Belgium, France |
|
Pantoprazole sodium sesquihydrate |
♦ |
♦ |
Europe, USA |
|
Tertiobutylchlorobutyrophenone |
♦ |
|
USA |
|
Tocofersolan ( Vit. E TPGS ) |
♦ | Europe, USA | |
|
Trimebutine base |
♦ |
|
France |
|
Trimebutine maleate |
♦ |
♦ |
Canada, Europe, France, Italy, USA |
REACH
« One of the main objectives of REACH Regulation is to increase and promote innovation by providing encouragement to innovate for research-orientated companies » (From ECHA November 2014 – Guidance on Scientific R&D (SR&D) and Product and Process Orientated Research and Development (PPORD)).
Deeply involved in REACH Regulation, PMC Isochem has about 60 registrations and manages close relationship with its cutomers and suppliers to ensure a reliable supply chain.
In cooperation with UIC and SICOS councils, PMC Isochem also notifies intermediates manufactured under strictly controlled conditions for the protection of workers and the environment.
